Giuseppe Fanelli
Giuseppe Fanelli, MD, PhD is an expert in Pharmacy at Radboud University Nijmegen Medical Centre (Netherlands). Giuseppe Fanelli has authored 150 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 453 (community average: 125). How the SLR is computed.
LeadR Profile
Pharmacy
Subspecialties: Psychiatry - Neurology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2016 - 2026
Number : 150
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Therapy-induced senescence in breast cancer and cardiovascular disease: a double-edged biological process. PMID 42871672 — cells, breast neoplasms, aging, cardiovascular diseases, neoplasms, phenotype, breast, therapeutics, tissues | Front Cardiovasc Med | 2026 | 0 |
| Inflammatory protein signatures as predictors of insulin resistance and cognitive function: a one-year longitudinal study in the mPRIME cohort. PMID 42830766 — cytokines, cells, longitudinal studies, insulin resistance, insulin, cognition | Brain Behav Immun Health | 2026 | 0 |
| Spatial statistics infer structured immune signatures in primary prostate cancer. PMID 42726512 — cells, lymphocytes, cold temperature, neoplasms, prostate, prostatic neoplasms, b-lymphocytes | Cancer Immunol Res | 2026 | 0 |
| Integrated signatures define mutational processes in prostate cancer. PMID 42717097 — androgens, receptors, androgen, mutagenesis, neoplasms, prostate, genome, prostatic neoplasms | Nature Top journal | 2026 | 2 |
| Recurrent mechanisms of biallelic epigenetic inactivation reveal new putative tumour suppressor genes in prostate cancer. PMID 42716948 — genes, genes, suppressor, biological science disciplines, neoplasms, prostate, prostatic neoplasms, alleles | Nat Commun | 2026 | 1 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 2
LeadR Networks
Main global connection map